Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03337919
What this trial is testing

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University College, London 78
Not applicableLooking for participantsNCT05444712
What this trial is testing

Transplantation After Complete Response In Patients With T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Hospices Civils de Lyon 204
Not applicableUnknownNCT03764228
What this trial is testing

Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute-graft-versus-host Disease
Peking University People's Hospital 27
Not applicableLooking for participantsNCT06155188
What this trial is testing

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

Who this might be right for
LeukemiaStem Cell TransplantCord Blood
Nanfang Hospital, Southern Medical University 60
Post-approval studies (Phase 4)Study completedNCT01856803
What this trial is testing

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis

Who this might be right for
Leukemia, GVHD, ATG, Transplantation
Peking University People's Hospital 300
Testing effectiveness (Phase 2)UnknownNCT05413356
What this trial is testing

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeHematologic Malignancy
First Affiliated Hospital of Zhejiang University 50
Not applicableStudy completedNCT04635397
What this trial is testing

Immunomonitoring After Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Centre Hospitalier Universitaire de Nice 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT02629120
What this trial is testing

High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Early research (Phase 1)UnknownNCT02456610
What this trial is testing

Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China

Who this might be right for
Viral Infection
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableUnknownNCT03593161
What this trial is testing

Humor Therapy and Distress After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Universitätsklinikum Hamburg-Eppendorf 126
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Not applicableUnknownNCT03964922
What this trial is testing

Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation

Who this might be right for
Relapse LeukemiaAllogeneic Stem Cell TransplantationImmune Evasion, Tumor
Central Hospital, Nancy, France 104
Large-scale testing (Phase 3)Looking for participantsNCT07463651
What this trial is testing

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-ITD MutationAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University 594
Testing effectiveness (Phase 2)Looking for participantsNCT07572669
What this trial is testing

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Steroid-Refractory Acute Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseGraft-Versus-Host Disease+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)Study completedNCT04118075
What this trial is testing

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

Who this might be right for
GVHD, Acute
Shanghai Jiao Tong University School of Medicine 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05873205
What this trial is testing

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Not Yet RecruitingNCT06825572
What this trial is testing

MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation

Who this might be right for
Liver FailureMesenchymal Stem CellExtracellular Vesicles
Third Affiliated Hospital, Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Study completedNCT00539695
What this trial is testing

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Who this might be right for
Acute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more
Baylor College of Medicine 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Next Page